Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06354491 · ClinicalTrials.gov registry record · NA
An Imaging-based Quantitative Biomarker Assay for NAFLD in Children
A NA study of NAFLD and NASH, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06354491 is a NA study of NAFLD and NASH that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 24 participants, below the 164-participant average among 26 other NAFLD trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06354491, a NA study of NAFLD and NASH, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will validate recently developed Magnetic Resonance Imaging (MRI) and Ultrasound (US) based methods for liver fat quantification in children with obesity and healthy range of body mass index (BMI).
Interventions
- DEVICE Magnetic Resonance Imaging (MRI)
- DEVICE Ultrasound (US)
Study Locations (1)
Wisconsin
- University of Wisconsin, Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06354491
The ClinicalTrials.gov registry entry for NCT06354491 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 26 other NAFLD trials with a reported enrollment target (85% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with NAFLD appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT06354491 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06354491 about?
NCT06354491 is a clinical study titled "An Imaging-based Quantitative Biomarker Assay for NAFLD in Children". This study will validate recently developed Magnetic Resonance Imaging (MRI) and Ultrasound (US) based methods for liver fat quantification in children with obesity and healthy range of body mass index (BMI).
What is the current status of trial NCT06354491?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-04-01. Estimated completion is 2028-07-01.
What conditions does trial NCT06354491 study?
This clinical trial studies the following conditions: NAFLD, NASH.
What interventions are being tested in trial NCT06354491?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DEVICE), Ultrasound (US) (DEVICE).
Who is sponsoring clinical trial NCT06354491?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06354491 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
NAFLD Clinical Care Pathway
RECRUITING · NA
-
NASH AMPK Exercise Dosing (AMPED) Trial
RECRUITING · NA
-
Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD
ACTIVE NOT RECRUITING · NA
-
The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)
COMPLETED · NA
-
Healthy Liver - Healthy Brain
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.